Likewise, the oligomerization of the glucagon-like peptide-1 receptor (GLP-1R) with the glucose-dependent insulinotropic polypeptide receptor (GIPR) in regulating post-endocytic insulin secretion offers a promising new approach for diabetes treatment [90]. Here, GLP1R is linked to diabetes mellitus.